| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 95.05M | 118.36M | 42.24M | 187.47M | 245.53M | 190.66M |
| Gross Profit | 95.05M | 117.70M | 26.80M | 170.46M | 232.12M | 179.94M |
| EBITDA | 0.00 | 107.51M | 24.33M | 4.02M | 2.21M | 2.49M |
| Net Income | 66.41M | 107.51M | 17.37M | 164.53M | 226.49M | 175.07M |
Balance Sheet | ||||||
| Total Assets | 1.38B | 1.48B | 1.31B | 1.37B | 1.17B | 952.87M |
| Cash, Cash Equivalents and Short-Term Investments | 20.85M | 3.93M | 9.72M | 20.69M | 41.33M | 45.14M |
| Total Debt | 89.75M | 131.93M | 20.00M | 65.29M | 0.00 | 0.00 |
| Total Liabilities | 97.72M | 143.10M | 25.14M | 65.29M | 9.30M | 851.00K |
| Stockholders Equity | 1.29B | 1.33B | 1.28B | 1.30B | 1.16B | 952.02M |
Cash Flow | ||||||
| Free Cash Flow | 75.44M | -57.39M | 79.41M | 164.53M | 226.49M | 49.92M |
| Operating Cash Flow | 75.44M | -57.39M | 79.41M | 164.53M | 226.49M | 49.92M |
| Investing Cash Flow | 0.00 | 0.00 | 94.67M | -225.30M | -205.43M | 54.92M |
| Financing Cash Flow | -67.45M | 51.22M | -91.15M | 39.72M | -23.90M | -18.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £27.08B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
76 Outperform | £1.73B | ― | 2.24% | 2.40% | 64.34% | 77.61% | |
71 Outperform | £497.88M | 10.05 | 9.58% | 5.79% | 82.69% | 21.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.58B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
66 Neutral | £832.44M | -13.06 | 5.07% | 2.47% | 66.53% | 100.92% | |
54 Neutral | £2.12B | 56.55 | 4.25% | 2.85% | 62.91% | -15.13% |